BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
0.8942
+0.0540 (6.42%)
Apr 24, 2025, 4:00 PM EDT - Market closed
BioVie Market Cap
BioVie has a market cap or net worth of $16.50 million as of April 25, 2025. Its market cap has decreased by -12.24% in one year.
Market Cap
16.50M
Enterprise Value
-7.52M
1-Year Change
-12.24%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $16.50M, a decrease of -68.27%. That is a compound annual growth rate of -22.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 15.50M | -56.34% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.84B |
| UnitedHealth Group | 385.37B |
| Johnson & Johnson | 379.38B |
| AbbVie | 306.51B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 227.68B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |